Meso Numismatics closes Global Stem Cells Group acquisition; renegotiates $10.5M financing

Regenerative Medical Technology Group Inc.

Acquired all GCSC shares for 1M Series AA Preferred, 8,974 Series DD Preferred, and $225,000 cash.
Issuance of 1M Series AA Preferred to Benito Novas caused change of control; Novas and CEO jointly control 67% vote.
Renegotiated June 2021 $10.5M financing: warrant maturity extended to 7 years, locked up for first 2 years.
$8.2M earmarked for Lans Holdings escrow per prior agreement.
Entered consulting agreement with ETC (owned by CEO) for 896 Series DD Preferred shares.

item 1.01 item 2.01 item 3.02 item 5.01 item 5.02 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.